stockrowRadNet, Inc.
RDNT Healthcare Diagnostics & Research
RadNet, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.0 billion, up 11.5% from fiscal 2024.
- Revenue
- +25.0%
- EPS
- −47.4%
- Free cash flow
- −43.2%
- Total debt
- +21.2%
Quarter to June 2026, against a year earlier
Follow RDNT
Alert me
RadNet, Inc. (RDNT) Gross margin
RadNet, Inc.'s gross margin over the twelve months to 30 June 2026 was 11.5%, down 0.0 percentage points from fiscal 2025 (11.5%). Over the past ten years it has ranged from 9.88% (fiscal 2020) to 14.6% (fiscal 2021); the current reading is higher than 27% of that period. That is below the Diagnostics & Research industry median of 48.3% and below the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 11.5% | (2.08) |
| FY2024 | 13.6% | (0.07) |
| FY2023 | 13.7% | 2.10 |
| FY2022 | 11.6% | (2.99) |
| FY2021 | 14.6% | 4.70 |
| FY2020 | 9.88% | (3.51) |
| FY2019 | 13.4% | 2.36 |
| FY2018 | 11.0% | (1.96) |
| FY2017 | 13.0% | 0.70 |
| FY2016 | 12.3% | (0.23) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 14.1% | 9.78 |
| Mar 2026 | 4.36% | (9.50) |
| Dec 2025 | 13.9% | 0.00 |
| Sep 2025 | 13.9% | (0.02) |
| 42 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| ADPT Adaptive Biotechnologies Corporation compare | 74.2% |
| VCYT Veracyte, Inc. compare | 72.0% |
| BLLN BillionToOne, Inc. compare | 71.4% |
| CDNA CareDx, Inc. compare | 71.0% |
| QGEN QIAGEN N.V. compare | 62.2% |
| SHC Sotera Health Company compare | 54.6% |
| ICLR ICON PLC compare | 23.4% |
| RDNT RadNet, Inc. | 11.5% |
| GRAL GRAIL, Inc. compare | 0.00% |
| Diagnostics & Research industry median | 48.3% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on RDNT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement